Search Results for: NCM-MCI-6.5 Tests 🍟 NCM-MCI-6.5 Online Test 🍰 NCM-MCI-6.5 Demotesten 📔 Suchen Sie jetzt auf ▶ www.itzert.com ◀ nach ▛ NCM-MCI-6.5 ▟ und laden Sie es kostenlos herunter 😭NCM-MCI-6.5 Zertifizierungsfragen
Expanded studies of CEM-101, a novel fluoroketolide, tested against invasive isolates of N. meningitidis,including fluoroquinolone-non-susceptible resistant strains
Expanded studies of CEM-101, a novel fluoroketolide, tested against invasive isolates of N. meningitidis,including fluoroquinolone-non-susceptible resistant strains, Lead author: Biedenbach DJ, presented at 20th annual European Congress of Clinical Microbiology…
Telavancin In Vitro Activity Against a Contemporary(2011–2012) Collection of Gram-positive Pathogens
Telavancin In Vitro Activity Against a Contemporary(2011–2012) Collection of Gram-positive Pathogens, Lead author: Mendes RE, presented at 9th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 12 –…
Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Blood Stream Infections: SENTRY Antimicrobial Surveillance Program, 1997-2000
Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Blood Stream Infections: SENTRY Antimicrobial Surveillance Program, 1997-2000, presented at 41st annual Interscience Conference of Antimicrobial…
In Vitro Efficacy of Tigecycline Tested Against Community-acquired Respiratory Tract Infection and Nosocomial Pneumonia Pathogens
In Vitro Efficacy of Tigecycline Tested Against Community-acquired Respiratory Tract Infection and Nosocomial Pneumonia Pathogens, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious…
Clonal expansion of Acinetobacter baumannii strains displaying elevated tigecycline minimum inhibitory concentration (MIC) values responsible for increasing resistance rates in Latin America (eposter)
Clonal expansion of Acinetobacter baumannii strains displaying elevated tigecycline minimum inhibitory concentration (MIC) values responsible for increasing resistance rates in Latin America (eposter), Lead author: Castanheira M, presented at 23rd…
Trends in Antimicrobial Susceptibility of Bacterial Pathogens Isolated from Patients with Blood Stream Infections (BSI) in North America (NA): SENTRY Program, 1997-2000
Trends in Antimicrobial Susceptibility of Bacterial Pathogens Isolated from Patients with Blood Stream Infections (BSI) in North America (NA): SENTRY Program, 1997-2000, presented at 41st annual Interscience Conference of Antimicrobial…
Activity of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens
Activity of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens, Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April…
In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity
In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17…
Extreme Variations in Susceptibility (S) of P. aeruginosa (PSA) Among Hospitals in North America (NA), Latin America (LA), Europe (EU) and the Asia-Pacific (AP): Report from the SENTRY Antimicrobial Surveillance Program, 1997-2000
Extreme Variations in Susceptibility (S) of P. aeruginosa (PSA) Among Hospitals in North America (NA), Latin America (LA), Europe (EU) and the Asia-Pacific (AP): Report from the SENTRY Antimicrobial Surveillance…
Changing Antimicrobial Susceptibility Patterns Among S. pneumoniae and H. influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2003)
…the SENTRY Antimicrobial Surveillance Program (1998-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark…